Cerebral lymphomatoid granulomatosis. A report of two cases, with disseminated necrotizing leukoencephalopathy in one

Acta Neuropathologica
|October 15, 1976
PubMed

Insights

This study presents two cases of cerebral lymphomatoid granulomatosis, detailing neuropathologic findings and treatment responses. One patient developed intracranial hypertension, while the other showed signs of leukoencephalopathy after therapy.

Area of Science:

  • Neuropathology
  • Oncology
  • Immunology

Background:

  • Cerebral lymphomatoid granulomatosis (CLG) is a rare lymphoproliferative disorder with potential neurological sequelae.
  • Understanding the neuropathologic manifestations and treatment outcomes of CLG is crucial for patient management.

Observation:

  • Case 1: A 30-year-old male with pulmonary lymphomatoid granulomatosis developed acute intracranial hypertension and coma following Prednisone therapy, with neuropathology revealing a necrotizing lesion in the left putamen.
  • Case 2: An 18-year-old female with pulmonary lymphomatoid granulomatosis presented with neurological deficits suggestive of a brain mass. Despite treatment with irradiation and chemotherapy, she relapsed and was found to have disseminated necrotizing leukoencephalopathy post-mortem.

Findings:

  • Neuropathologic examination in Case 1 showed atypical lymphoplasmacytic infiltration surrounding a necrotizing hemorrhagic lesion.
  • Case 2's autopsy revealed parenchymatous degeneration consistent with disseminated necrotizing leukoencephalopathy, rather than active CLG, suggesting a treatment-related complication.

Implications:

  • These cases highlight the diverse neuropathologic sequelae of lymphomatoid granulomatosis and its treatments.
  • The findings underscore the importance of considering treatment-induced neurotoxicity, such as disseminated necrotizing leukoencephalopathy, in patients with a history of lymphoproliferative disorders and chemotherapy.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...